{
  "@context": "aku-v2",
  "@type": "clinical-concept",
  "@id": "vascular:lymphatic:lymph-015-chylothorax",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-07T00:40:00.000Z",
    "contributors": [
      "copilot-agent",
      "knowledge-graph-agent"
    ],
    "confidence": 0.95,
    "status": "enhanced",
    "last_updated": "2026-01-07T00:40:00.000Z",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/lymphatic",
    "type": "complication",
    "difficulty": "advanced",
    "importance": "high",
    "aku_id": "LYMPH-015",
    "keywords": [
      "chylothorax",
      "thoracic duct injury",
      "chyle leak",
      "lymphatic complications"
    ],
    "medical_specialty": "vascular_surgery",
    "clinical_context": "lymphatic_disease",
    "isNativeDomain": true
  },
  "content": {
    "statement": "vascular:lymphatic:lymph-015-chylothorax is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Lymphatic that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding vascular:lymphatic:lymph-015-chylothorax helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of vascular:lymphatic:lymph-015-chylothorax include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of vascular:lymphatic:lymph-015-chylothorax."
    }
  },
  "clinical_features": {
    "etiology": {
      "surgical": {
        "esophagectomy": "2-4% incidence, highest risk",
        "cardiac_surgery": "0.5-2%, especially left thoracic approach",
        "lung_resection": "Especially left lower lobe",
        "neck_dissection": "Left side risk for duct injury at venous angle",
        "spine_surgery": "Thoracic or lumbar approaches"
      },
      "non_surgical": {
        "malignancy": "Lymphoma most common, direct invasion or obstruction",
        "trauma": "Penetrating or blunt thoracic injury",
        "congenital": "Thoracic duct atresia, lymphangiomatosis",
        "thrombosis": "SVC or left subclavian vein thrombosis"
      }
    },
    "diagnosis": {
      "pleural_fluid_analysis": {
        "appearance": "Milky or turbid (may be serous if fasting)",
        "triglycerides": ">110 mg/dL (diagnostic threshold)",
        "cholesterol": "Low, cholesterol:TG ratio <1",
        "chylomicrons": "Present on lipoprotein electrophoresis",
        "lymphocytes": "Predominant cell type (>80%)"
      },
      "imaging": {
        "chest_X_ray": "Pleural effusion, usually left-sided",
        "CT": "Effusion, may show underlying mass",
        "lymphangiography": "Identifies leak location (largely replaced by lymphoscintigraphy)"
      }
    },
    "complications": {
      "nutritional": "Malnutrition, fat-soluble vitamin deficiency, essential fatty acid deficiency",
      "immunologic": "Lymphopenia, T-cell depletion, increased infection risk",
      "respiratory": "Dyspnea from effusion, potential respiratory failure",
      "metabolic": "Electrolyte imbalances, hypoalbuminemia"
    },
    "management": {
      "conservative": {
        "dietary": "NPO or medium-chain triglyceride (MCT) diet (MCT absorbed directly to portal vein)",
        "drainage": "Chest tube or repeated thoracentesis",
        "TPN": "Total parenteral nutrition to rest the duct",
        "octreotide": "Reduces intestinal lymph production",
        "duration": "2 weeks trial before escalating"
      },
      "interventional": {
        "thoracic_duct_embolization": "Percutaneous approach via lymphangiography and glue embolization",
        "pleurodesis": "Chemical pleurodesis for refractory low-output leaks"
      },
      "surgical": {
        "thoracic_duct_ligation": "VATS or open approach at the diaphragmatic hiatus",
        "mass_ligation": "En bloc ligation of tissue between aorta and azygos at T8-T12",
        "pleurectomy": "For refractory cases"
      }
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Chylothorax"
    },
    "altLabel": [
      "Chyle leak",
      "Thoracic duct injury",
      "Chylous pleural effusion"
    ],
    "definition": {
      "@language": "en",
      "@value": "Accumulation of lymphatic chyle in the pleural space due to thoracic duct injury or obstruction, characterized by triglyceride-rich milky fluid causing nutritional, immunologic, and respiratory compromise."
    },
    "notation": "LYMPH-015"
  },
  "relationships": {
    "prerequisites": [
      "vascular:lymphatic:lymph-002-anatomy"
    ],
    "enables": [],
    "skos:broader": [
      "vascular:lymphatic:complications"
    ],
    "skos:related": [
      "vascular:lymphatic:lymph-016-chylous-ascites"
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). vascular:lymphatic:lymph-015-chylothorax. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  },
  "pedagogical": {
    "target_audience": [
      "thoracic surgery residents",
      "vascular surgery residents",
      "cardiothoracic surgeons"
    ],
    "estimated_time": "20min",
    "learning_objectives": [
      "Define chylothorax and identify diagnostic criteria",
      "List the major causes of chylothorax",
      "Outline the stepwise management algorithm",
      "Understand the nutritional and immunologic consequences"
    ],
    "clinical_pearls": [
      "Triglycerides >110 mg/dL is diagnostic - always send pleural TG levels",
      "Left-sided chylothorax = distal duct injury (T4-T12); right-sided = proximal (above T5)",
      "MCT diet works because MCTs bypass lymphatics, going directly to portal circulation",
      "Trial conservative management for 2 weeks before surgical intervention",
      "High output (>1L/day) requires aggressive management - low threshold for surgery",
      "Chylothorax causes lymphopenia and immunocompromise - monitor infection risk"
    ],
    "board_yield": "HIGH"
  },
  "medicalCode": [
    {
      "codingSystem": "SNOMED-CT",
      "codeValue": "9566005",
      "description": "Chylothorax"
    },
    {
      "codingSystem": "ICD-10-CM",
      "codeValue": "J94.0",
      "description": "Chylous effusion"
    }
  ]
}